Global Multiple Myeloma Market Analysis, 2020

Global Multiple Myeloma Market Analysis, 2020

By Test Type (Blood, Biopsy, Imaging [X-rays, CT scan (Computed tomography scan), Magnetic resonance imaging (MRI) scans, Positron emission tomography (PET) scan, Echocardiogram (ECHO)], Others (Urine Read more

  • Healthcare
  • Jul 2020
  • 204
  • HC55009

Multiple Myeloma is type of cancer that develops in the plasma cells which affects the bone marrow of the body.

Global Multiple Myeloma Market Analysis, 2020 research report depicts a deep-dive market analysis of statistics of Global Multiple Myeloma market which consists of regional and country-wise market size, market forecast, CAGR market segmentation, market shares of diverse regions and countries, market share of various end users, applications, product type, technologies, competitive benchmarking, etc.

 

According to MarkNtel Advisors’ research report titled “Global Multiple Myeloma Market Analysis, 2020”, the Global Multiple Myeloma market is anticipated to grow at a CAGR of around 6% during 2020-25F. Laboratories segment acquired the considerable market share in the Multiple Myeloma market in 2019 owing to the rising investment by pharma companies for the research and development of novel drugs for the treatment.

Chemotherapy Acquired the Substantial Market Share
Based on Medication, chemotherapy acquired the substantial market share owing to the limited surgical procedures, absence of alternative medication along with ongoing development of several pipeline drugs in chemotherapy. Target therapy is also gaining robust pace in the market on an account of surging adoption of immunomodulating drugs coupled with the approval and launch of monoclonal antibodies, such as Empliciti and Darzalex in the market which is expected to proliferate the growth of the Multiple Myeloma market in the coming year as stated in the MarkNtel Advisors’ research report “Global Multiple Myeloma Market Analysis, 2020”.  

 
According to MarkNtel Advisors, the key players with a considerable market share in the Global Multiple Myeloma market include Janssen Biotech, Bristol-Myers Squibb, Novartis, Celgene, Kesios Therapeutics, Amgen, Sanofi Genzyme, Juno Therapeutics, Takeda, Karyopharm etc.

Key Questions Answered in the Market Research Report 

  1. What are the key overall market statistics or market estimates (Market Overview, Market Size- By Value, Forecast Numbers, Market Segmentation, Market Shares) of Global Multiple Myeloma Market?
  2. What is the region wise industry size, growth drivers and challenges key market trends?
  3. What are the key innovations, technology upgrades, opportunities, regulations in the Global Multiple Myeloma Market?  
  4. Who are the key competitors or market players and how they perform in Global Multiple Myeloma Market based on competitive benchmarking matrix?
  5. What are the key results derived from the market surveys conducted during the course of Global Multiple Myeloma Market study?   

Market Outlook, Segmentation and Statistics 

  • Global Multiple Myeloma Start-ups Ecosystem
  • Impact of COVID-19 on Global Multiple Myeloma Market
  • Market Size & Analysis
    • By Revenues (USD Million)
  • Market Share & Analysis
    • By Test Type
      • Blood 
      • Biopsy
      • Imaging 
        • X-rays
        • CT scan (Computed tomography scan)
        • Magnetic resonance imaging (MRI) scans
        • Positron emission tomography (PET) scan
        • Echocardiogram (ECHO)
        • Others (Urine test, etc.)
    • By Medication
      • Chemotherapy
        • Anthracycline antiobiotic
        • Alkylating agent
      • Targeted Therapies
        • Immunomodulatory Drugs
        • Monoclonal Antibodies
        • Proteasome Inhibitors
        • Histone Deacetylase (HDAC) Inhibitors
        • Others (Nuclear export inhibitor,etc.)
      • Radiation Therapy
      • Stem Cell Transplant 
      • Supportive Treatments
    • By End Users
      • Hospitals & Specialty Centers
      • Laboratories
      • Others
    • By Region
      • North America Multiple Myeloma Market Outlook, 2015-2025F (USD Million)
        • The US Multiple Myeloma Market Outlook, 2015-2025F (USD Million)
        • Canada Multiple Myeloma Market Outlook, 2015-2025F (USD Million)
        • Mexico Multiple Myeloma Market Outlook, 2015-2025F (USD Million)
      • South America Multiple Myeloma Market Outlook, 2015-2025F (USD Million)
        • Brazil Multiple Myeloma Market Outlook, 2015-2025F (USD Million)
        • Argentina Multiple Myeloma Market Outlook, 2015-2025F (USD Million)
      • Europe Multiple Myeloma Market Outlook, 2015-2025F (USD Million)
        • The UK Multiple Myeloma Market Outlook, 2015-2025F (USD Million)
        • Germany Multiple Myeloma Market Outlook, 2015-2025F (USD Million)
        • France Multiple Myeloma Market Outlook, 2015-2025F (USD Million)
        • Italy Multiple Myeloma Market Outlook, 2015-2025F (USD Million)
        • Spain Multiple Myeloma Market Outlook, 2015-2025F (USD Million)
        • The Netherlands Multiple Myeloma Market Outlook, 2015-2025F (USD Million)
      • Middle East & Africa Multiple Myeloma Market Outlook, 2015-2025F (USD Million)
        • UAE Multiple Myeloma Market Outlook, 2015-2025F (USD Million)
        • Saudi Arabia Multiple Myeloma Market Outlook, 2015-2025F (USD Million)
        • South Africa Multiple Myeloma Market Outlook, 2015-2025F (USD Million)
      • Asia-Pacific Multiple Myeloma Market Outlook, 2015-2025F (USD Million)
        • China Multiple Myeloma Market Outlook, 2015-2025F (USD Million)
        • Japan Multiple Myeloma Market Outlook, 2015-2025F (USD Million)
        • India Multiple Myeloma Market Outlook, 2015-2025F (USD Million)
        • South Korea Multiple Myeloma Market Outlook, 2015-2025F (USD Million) 
        • South East Asia Multiple Myeloma Market Outlook, 2015-2025F (USD Million)
  • By Company
    • Revenue Shares
    • Strategic Factorial Indexing
    • Competitor Placement in MarkNtel Quadrant
  • Global Multiple Myeloma Market Policies, Regulations, Product Standard
  • Global Multiple Myeloma Market - Value Chain Analysis
  • Global Multiple Myeloma Market Hotspots & Opportunities
  • Competition Outlook
    • Competitor Wise Growth Strategies
    • Company Profiles

Frequently Asked Questions 

Q. What is the historical year, base year and forecast year considered in the research report on Global Multiple Myeloma Market?
A. The historical data has been provided since 2015, while the base year is 2019 and the data is forecast up-to 2025.

Q. What are the units or denomination for measuring market value and volume in the report?
A. The market size/industry size or the market value is measured in terms of USD Million. 

Q. What would be the growth rate or CAGR of Global Multiple Myeloma Market during 2020-25?
A. The growth rate of Global Multiple Myeloma Market during 2020-25 is forecast to be grow at a CAGR of 6%.

Q. Who are the key competitors or players operating in Global Multiple Myeloma Market? 
A. Janssen Biotech, Bristol-Myers Squibb, Novartis, Celgene, Kesios Therapeutics, Amgen, Sanofi Genzyme, Juno Therapeutics, Takeda, Karyopharm etc., are few of the leading players in the Global Multiple Myeloma Market.

Q. Which medication segment would emerge as an opportunity area for players in Global Multiple Myeloma Market?
A. Targeted therapies segment is expected to attain the highest CAGR during the forecast period and maintain its significant market share.

Q. Which region would emerge as an opportunity area for players in Global Multiple Myeloma Market?
A. North America grabbed a majority market share continue to grow at a highest CAGR, presenting immense opportunities for the market player in the Global Multiple Myeloma Market.

  1. Introduction
    1. Product Definition
    2. Research Process
    3. Market Segmentation
    4. Assumptions
  2. Executive Summary
  3. Global Multiple Myeloma Overview
  4. Global Multiple Myeloma Startups Ecosystem
  5. Impact of COVID-19 on Global Multiple Myeloma Market
  6. Expert Verbatim-Interview Excerpts of industry experts
  7. Global Multiple Myeloma Market Outlook, 2015-2025
    1. Market Size & Analysis
      1. Revenues
    2. Market Share & Analysis
      1. By Test Type
        1. Blood
        2. Biopsy
        3. Imaging
          1. X-rays
          2. CT scan (Computed tomography scan)
          3. Magnetic resonance imaging (MRI) scans
          4. Positron emission tomography (PET) scan
          5. Echocardiogram (ECHO)
        4. Others (Urine test, etc.)
      2. By Medication
        1. Chemotherapy
          1. Anthracycline antiobiotic
          2. Alkylating agent
        2. Targeted Therapies
          1. Immunomodulatory Drugs
          2. Monoclonal Antibodies
          3. Proteasome Inhibitors
          4. Histone Deacetylase (HDAC) Inhibitors
          5. Others (Nuclear export inhibitor,etc.)
        3. Radiation Therapy
        4. Stem Cell Transplant
        5. Supportive Treatments
      3. By End Users
        1. Hospitals & Specialty Centers
        2. Laboratories
        3. Others
      4. By Region
        1. North America
        2. South America
        3. Europe
        4. Middle East & Africa
        5. Asia-Pacific
      5. By Company
        1. Market Shares, By Revenue
        2. Strategic Factorial Indexing
        3. Competitor Placement in MarkNtel Quadrant
    3. Market Attractiveness Index
      1. By Test Type
      2. By Medication
      3. By End Users
      4. By Region
  8. North America Multiple Myeloma Market Outlook, 2015-2025
    1. Market Size & Analysis
      1. Revenues
    2. Market Share & Analysis
      1. By Test Type
      2. By Medication
      3. By End Users
      4. By Country
        1. The US
        2. Canada
        3. Mexico
    3. The US Multiple Myeloma Market Outlook, 2015-2025
      1. Market Size & Analysis
        1. Revenues
      2. Market Share & Analysis
        1. By Test Type
        2. By Medication
    4. Canada Multiple Myeloma Market Outlook, 2015-2025
      1. Market Size & Analysis
        1. Revenues
      2. Market Share & Analysis
        1. By Test Type
        2. By Medication
    5. Mexico Multiple Myeloma Market Outlook, 2015-2025
      1. Market Size & Analysis
        1. Revenues
      2. Market Share & Analysis
        1. By Test Type
        2. By Medication
  9. South America Multiple Myeloma Market Outlook, 2015-2025
    1. Market Size & Analysis
      1. Revenues
    2. Market Share & Analysis
      1. By Test Type
      2. By Medication
      3. By End Users
      4. By Country
        1. Brazil
        2. Argentina
        3. Others
    3. Brazil Multiple Myeloma Market Outlook, 2015-2025
      1. Market Size & Analysis
        1. Revenues
      2. Market Share & Analysis
        1. By Test Type
        2. By Medication
    4. Argentina Multiple Myeloma Market Outlook, 2015-2025
      1. Market Size & Analysis
        1. Revenues
      2. Market Share & Analysis
        1. By Test Type
        2. By Medication
  10. Europe Multiple Myeloma Market Outlook, 2015-2025
    1. Market Size & Analysis
      1. Revenues
    2. Market Share & Analysis
      1. By Test Type
      2. By Medication
      3. By End Users
      4. By Country
        1. Germany
        2. The UK
        3. France
        4. Italy
        5. Spain
        6. The Netherlands
        7. Others
    3. Germany Multiple Myeloma Market Outlook, 2015-2025
      1. Market Size & Analysis
        1. Revenues
      2. Market Share & Analysis
        1. By Test Type
        2. By Medication
    4. The UK Multiple Myeloma Market Outlook, 2015-2025
      1. Market Size & Analysis
        1. Revenues
      2. Market Share & Analysis
        1. By Test Type
        2. By Medication
    5. France Multiple Myeloma Market Outlook, 2015-2025
      1. Market Size & Analysis
        1. Revenues
      2. Market Share & Analysis
        1. By Test Type
        2. By Medication
    6. Italy Multiple Myeloma Market Outlook, 2015-2025
      1. Market Size & Analysis
        1. Revenues
      2. Market Share & Analysis
        1. By Test Type
        2. By Medication
    7. Spain Multiple Myeloma Market Outlook, 2015-2025
      1. Market Size & Analysis
        1. Revenues
      2. Market Share & Analysis
        1. By Test Type
        2. By Medication
    8. The Netherlands Multiple Myeloma Market Outlook, 2015-2025
      1. Market Size & Analysis
        1. Revenues
      2. Market Share & Analysis
        1. By Test Type
        2. By Medication
  11. Middle East & Africa Multiple Myeloma Market Outlook, 2015-2025
    1. Market Size & Analysis
      1. Revenues
    2. Market Share & Analysis
      1. By Test Type
      2. By Medication
      3. By End Users
      4. By Country
        1. UAE
        2. Saudi Arabia
        3. South Africa
        4. Others
    3. UAE Multiple Myeloma Market Outlook, 2015-2025
      1. Market Size & Analysis
        1. Revenues
      2. Market Share & Analysis
        1. By Test Type
        2. By Medication
    4. Saudi Arabia Multiple Myeloma Market Outlook, 2015-2025
      1. Market Size & Analysis
        1. Revenues
      2. Market Share & Analysis
        1. By Test Type
        2. By Medication
    5. South Africa Multiple Myeloma Market Outlook, 2015-2025
      1. Market Size & Analysis
        1. Revenues
      2. Market Share & Analysis
        1. By Test Type
        2. By Medication
  12. Asia-Pacific Multiple Myeloma Market Outlook, 2015-2025
    1. Market Size & Analysis
      1. Revenues
    2. Market Share & Analysis
      1. By Test Type
      2. By Medication
      3. By End Users
      4. By Country
        1. China
        2. India
        3. Japan
        4. South Korea
        5. South East Asia
        6. Others
    3. China Multiple Myeloma Market Outlook, 2015-2025
      1. Market Size & Analysis
        1. Revenues
      2. Market Share & Analysis
        1. By Test Type
        2. By Medication
    4. India Multiple Myeloma Market Outlook, 2015-2025
      1. Market Size & Analysis
        1. Revenues
      2. Market Share & Analysis
        1. By Test Type
        2. By Medication
    5. Japan Multiple Myeloma Market Outlook, 2015-2025
      1. Market Size & Analysis
        1. Revenues
      2. Market Share & Analysis
        1. By Test Type
        2. By Medication
    6. South Korea Multiple Myeloma Market Outlook, 2015-2025
      1. Market Size & Analysis
        1. Revenues
      2. Market Share & Analysis
        1. By Test Type
        2. By Medication
    7. South East Asia Multiple Myeloma Market Outlook, 2015-2025
      1. Market Size & Analysis
        1. Revenues
      2. Market Share & Analysis
        1. By Test Type
        2. By Medication
  13. Global Multiple Myeloma Market Policies, Regulations, Product Standards
  14. Global Multiple Myeloma Market Trends & Insights
  15. Global Multiple Myeloma Market Dynamics
    1. Growth Drivers
    2. Challenges
    3. Impact Analysis
  16. Global Multiple Myeloma Market Hotspot & Opportunities
  17. Global Multiple Myeloma Market Key Strategic Imperatives for Success & Growth
  18. Competition Outlook
    1. Competition Matrix
      1. Product Portfolio
      2. Target Markets
      3. Target End Users
      4. Research & Development
      5. Strategic Alliances
      6. Strategic Initiatives
    2. Company Profiles of top companies (Business Description, Product Segments, Business Segments, Financials, Strategic Alliances/ Partnerships, Future Plans)
      1. Janssen Biotech
      2. Bristol-Myers Squibb
      3. Novartis
      4. Celgene
      5. Kesios Therapeutics
      6. Amgen
      7. Sanofi Genzyme
      8. Juno Therapeutics
      9. Takeda
      10. Karyopharm
  19. Disclaimer
Global Multiple Myeloma Market Segmentation